InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the complete record of transactions filed by Jooss Karin, Autre. Director active across 2 companies, notably Fate Therapeutics INC. In total, 8 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €31k. Activity tracked since 2 June 2021. The latest transaction was disclosed on 15 May 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Jooss Karin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
27,128 股0Common StockSEC:0001415889-24-013655:0
40,000 股0Common StockSEC:0001415889-24-002714:0
252,763 股0Common StockSEC:0001567619-23-001947:0
8,650 股0Common StockSEC:0001209191-22-036349:0
1,483 股@ US$22.820.015% mcap100.0% 占其流量Common StockSEC:0001209191-22-034551:0
27,600 股0Common StockSEC:0001567619-22-008721:0
27,900 股0Common StockSEC:0001567619-21-020867:0
2,681 股0Common StockSEC:0000899243-21-022081:0
8 条申报中的 8 条
About Jooss Karin
Karin Jooss is a Director at Fate Therapeutics Inc and Gritstone bio, Inc. Her role is described as 'see remarks', indicating that she may have varied responsibilities within these companies. Her contribution is essential for the development and strategy of these biopharmaceutical firms.
